IL20RB-AS1

Across TCGA pan-cancer cohorts, IL20RB-AS1 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated IL20RB-AS1 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher IL20RB-AS1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated IL20RB-AS1 expression acts as an unfavorable survival marker, although some lineages such as ESCA and CHOL show a favorable association.

KIRC, MESO, and COAD are the cancer types where IL20RB-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Median	All	0.520	0.733	<.001	101	view →
MESO	DFS	Tertile	III,IV	0.122	0.573	.001	43	view →
COAD	OS	Tertile	II,III,IV	0.621	0.818	.009	42	view →
DLBC	OS	Median	III,IV	0.272	1.000	.017	31	view →
KIRP	DFS	Tertile	All	0.725	0.893	<.001	24	view →
PCPG	OS	Tertile	All	0.711	0.981	<.001	18	view →
READ	OS	Tertile	III,IV	0.389	0.857	.016	18	view →
ACC	OS	Tertile	IV	0.326	0.639	.014	15	view →
ESCA	OS	Quartile	III,IV	0.713	0.406	.034	15	view →
BLCA	DFS	Quartile	All	0.539	0.647	.019	9	view →
CHOL	DFS	Tertile	All	0.682	0.290	.022	6	view →
PAAD	OS	Quartile	II,III,IV	0.282	0.449	.014	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

IL20RB-AS1–KIRC (DFS)

Open the KIRC breakdown →